logo

For the Inventor, By the Inventor

Linz, Austria

Karlheinz Wegleitner

This inventor holds 7 USPTO granted patents. Top assignees: Chemie Linz Aktiengesellschaft, Lenzing Aktiengesellschaft. Active years: 1976-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karlheinz Wegleitner. Retrieved from https://idiyas.com/inventor/karlheinz-wegleitner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 45(Granted Patents)


Location History:

  • Linz (Danube), OE (1976)
  • Linz, Danube, OE (1976)
  • Linz, OE (1977)
  • Linz, AT (1978 - 1992)

Company Filing History:

goldMedal6 out of 76 
 
Chemie Linz Aktiengesellschaft
 patents
silverMedal1 out of 190 
 
Lenzing Aktiengesellschaft
 patents

Years Active: 1976-1992

Loading Chart...
7 patents (USPTO):Explore Patents
1. 5151273 - Delayed-release pharmaceutical preparation (1992-09-29),
2. 4278794 - Process for preparing pure cyanuric acid (1981-07-14),
3. 4265664 - Spirocyclic boron compounds, a process for their manufacture and their (1981-05-05),
4. 4130697 - Process for the production of foamed plastics with improved combustion (1978-12-19),
5. 4008234 - Process for the preparation of melon (1977-02-15),
6. 3984471 - Recovery of guanidine carbonate from aqueous solutions (1976-10-05),
7. 3952057 - Process for the preparation of guanidine carbonate (1976-04-20),

Title: The Innovative Contributions of Karlheinz Wegleitner

Introduction

Karlheinz Wegleitner is a notable inventor based in Linz, Austria. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work focuses on innovative solutions that enhance the effectiveness of pharmaceutical preparations.

Latest Patents

Wegleitner's latest patents include a delayed-release pharmaceutical preparation. This invention involves the formation of delayed-release tablets by incorporating hemicellulose and a matrix-forming adjuvant that does not disintegrate in a pharmaceutical dosage form containing the active substance or substances, preferably as a coated tablet or dragee. Another significant patent is the process for preparing pure cyanuric acid. This process involves introducing crude or waste melamine into 70 to 80% strength sulfuric acid at room temperature and heating the reaction mixture to a temperature range of 150 to 190 degrees Celsius, with the water introduced with the sulfuric acid being distilled off during the heating period.

Career Highlights

Throughout his career, Wegleitner has worked with prominent companies such as Chemie Linz Aktiengesellschaft and Lenzing Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Wegleitner has collaborated with several talented individuals, including Brigitta Korsatko-Wabnegg and

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…